Get started
Award

2018YFE0126500

Funded outputs count: 21
Funder award ID: 2018YFE0126500
OpenAlex ID: G7932027213
Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: Microbial-immune-metabolic network
2026 · Yuan-dong Sun, Xiao-Gang Dong, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 12
Multiomics reveals metformin’s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention
2025 · Yuan-dong Sun, Hao Zhang, et al. · Scientific Reports · 4
PDF
Impact of body mass index in patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors
2025 · Qishen Wang, Fang Liu, et al. · ONCOLOGIE · 2
PDF
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
2024 · Yuan-dong Sun, Hao Zhang, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 13
Data from Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFβ Axis
2023 · Yang Cheng, Fuxiang Bai, et al.
Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis
2023 · Panpan Tian, Wenwen Yang, et al. · Nature Communications · 66
PDF
A systematic review and meta-analysis comparing tumor progression and complications between radiofrequency ablation and thyroidectomy for papillary thyroid carcinoma
2022 · Yuan-dong Sun, Hao Zhang, et al. · Frontiers in Oncology · 13
PDF
Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes
2022 · Miao-Ling Chen, Chun-Xue Wu, et al. · Frontiers in Endocrinology · 14
T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐4 maintains adipose tissue homeostasis by orchestrating M2 macrophage polarization via nuclear factor kappa B pathway
2022 · Lu Ding, Yan Liang, et al. · Immunology · 12
PDF
NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
2022 · Xiaowei Guo, Siyu Tan, et al. · Hepatology · 81
LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1
2022 · Yang Sun, Yan Teng, et al. · Advanced Science · 47
N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
2022 · Siyuan Chen, Yuzhen Wang, et al. · Frontiers in Oncology · 12
PDF
Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFβ Axis
2022 · Yang Cheng, Fuxiang Bai, et al. · Cancer Research · 37
PDF
Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
2021 · Songbo Zhao, Chunhua Wang, et al. · Journal for ImmunoTherapy of Cancer · 45
PDF
Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1
2021 · Yuan-dong Sun, Hao Zhang, et al. · BMC Cancer · 6
PDF
Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
2021 · Siyu Tan, Xiaowei Guo, et al. · The Journal of Experimental Medicine · 26
CUL4B facilitates HBV replication by promoting HBx stabilization
2021 · Haixia Shan, Bo Wang, et al. · Cancer Biology and Medicine · 6
ZHX2 inhibits SREBP1c ‐mediated de novo lipogenesis in hepatocellular carcinoma via miR ‐24‐3p
2020 · Xiangguo Yu, Qinghai Lin, et al. · The Journal of Pathology · 39
Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma
2020 · Xiao-Jia Song, Chun-Hong Ma · Hepatoma Research · 4
PDF
Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3
2020 · Zehua Wang, Liang Kong, et al. · The Journal of Immunology · 60
PDF
Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling
2019 · Siyu Tan, Yong Xu, et al. · Cancer Research · 147
Year
Topic